{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T17:27:21Z","timestamp":1758475641567,"version":"3.37.3"},"reference-count":48,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T00:00:00Z","timestamp":1543190400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0207726","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T19:45:01Z","timestamp":1543261501000},"page":"e0207726","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["CSF macrophage migration inhibitory factor levels did not predict steroid treatment response after optic neuritis in patients with multiple sclerosis"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3080-2277","authenticated-orcid":true,"given":"Marc","family":"Pawlitzki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine M.","family":"Sweeney-Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven G.","family":"Meuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6441-9631","authenticated-orcid":true,"given":"Dirk","family":"Reinhold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"issue":"Pt 4","key":"ref1","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/brain\/awg081","article-title":"Early clinical predictors and progression of irreversible disability in multiple sclerosis. An amnesic process","volume":"126","author":"C Confavreux","year":"2003","journal-title":"Brain: a journal of neurology"},{"issue":"12","key":"ref2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1468-1331.2005.01352.x","article-title":"EFNS guideline on treatment of multiple sclerosis relapses. Report of an EFNS task force on treatment of multiple sclerosis relapses","volume":"12","author":"F Sellebjerg","year":"2005","journal-title":"European journal of neurology"},{"issue":"4","key":"ref3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11940-015-0345-6","article-title":"Therapeutic management of severe relapses in multiple sclerosis","volume":"17","author":"C Bevan","year":"2015","journal-title":"Current treatment options in neurology"},{"issue":"8","key":"ref4","doi-asserted-by":"crossref","first-page":"e0134583","DOI":"10.1371\/journal.pone.0134583","article-title":"Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis. A Retrospective Analysis of 90 Patients","volume":"10","author":"J Ehler","year":"2015","journal-title":"PloS one"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1742-2094-9-80","article-title":"Immunoadsorption therapy in patients with multiple sclerosis with steroid-refractory optical neuritis","volume":"9","author":"MJ Koziolek","year":"2012","journal-title":"Journal of neuroinflammation"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081749","article-title":"Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients-A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness","volume":"18","author":"J Ehler","year":"2017","journal-title":"International journal of molecular sciences"},{"issue":"9485","key":"ref7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","article-title":"Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange","volume":"366","author":"M Keegan","year":"2005","journal-title":"Lancet (London, England)"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12974-017-0929-z","article-title":"Pattern II and pattern III MS are entities distinct from pattern I MS. Evidence from cerebrospinal fluid analysis","volume":"14","author":"S Jarius","year":"2017","journal-title":"Journal of neuroinflammation"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders. A multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"S Jarius","year":"2016","journal-title":"Journal of neuroinflammation"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.msard.2018.01.010","article-title":"Beneficial effect of plasma exchange in acute attack of neuromyelitis optica spectrum disorders","volume":"20","author":"T Srisupa-Olan","year":"2018","journal-title":"Multiple sclerosis and related disorders"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1756285616637046","article-title":"Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration","volume":"9","author":"C Schneider-Gold","year":"2016","journal-title":"Therapeutic advances in neurological disorders"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1007\/s10620-016-4322-z","article-title":"A Macrophage Migration Inhibitory Factor Polymorphism Is Associated with Autoimmune Hepatitis Severity in US and Japanese Patients","volume":"61","author":"DN Assis","year":"2016","journal-title":"Digestive diseases and sciences"},{"issue":"11","key":"ref13","first-page":"806","article-title":"Macrophage activation syndrome in Chinese children with systemic onset juvenile idiopathic arthritis","volume":"44","author":"C-f Li","year":"2006","journal-title":"Zhonghua er ke za zhi = Chinese journal of pediatrics"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nri1200","article-title":"Macrophage migration inhibitory factor. A regulator of innate immunity","volume":"3","author":"T Calandra","year":"2003","journal-title":"Nature reviews. Immunology"},{"issue":"6448","key":"ref15","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/365756a0","article-title":"MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia","volume":"365","author":"J Bernhagen","year":"1993","journal-title":"Nature"},{"issue":"6544","key":"ref16","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/377068a0","article-title":"MIF as a glucocorticoid-induced modulator of cytokine production","volume":"377","author":"T Calandra","year":"1995","journal-title":"Nature"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ni720","article-title":"Development of chronic colitis is dependent on the cytokine MIF","volume":"2","author":"YP de Jong","year":"2001","journal-title":"Nature immunology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3389\/fimmu.2015.00577","article-title":"MIF. Implications in the Pathoetiology of Systemic Lupus Erythematosus","volume":"6","author":"T Lang","year":"2015","journal-title":"Frontiers in immunology"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.4049\/jimmunol.1200485","article-title":"Macrophage migration inhibitory factor potentiates autoimmune-mediated neuroinflammation","volume":"191","author":"GM Cox","year":"2013","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/art.38689","article-title":"Macrophage migration inhibitory factor inhibits the antiinflammatory effects of glucocorticoids via glucocorticoid-induced leucine zipper","volume":"66","author":"H Fan","year":"2014","journal-title":"Arthritis & rheumatology (Hoboken, N.J.)"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1212\/NXI.0000000000000139","article-title":"Macrophage migration inhibitory factor promotes resistance to glucocorticoid treatment in EAE","volume":"2","author":"N Ji","year":"2015","journal-title":"Neurology(R) neuroimmunology & neuroinflammation"},{"issue":"51","key":"ref22","doi-asserted-by":"crossref","first-page":"26502","DOI":"10.1074\/jbc.M116.743328","article-title":"Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential","volume":"291","author":"J Bloom","year":"2016","journal-title":"The Journal of biological chemistry"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-510X(00)00397-X","article-title":"Macrophage migration inhibitory factor in the cerebrospinal fluid of patients with conventional and optic-spinal forms of multiple sclerosis and neuro-Beh\u00e7et's disease","volume":"179","author":"M Niino","year":"2000","journal-title":"Journal of the neurological sciences"},{"issue":"1\u20132","key":"ref24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jneuroim.2011.02.009","article-title":"Disease-associated inflammatory biomarker profiles in blood in different subtypes of multiple sclerosis. Prospective clinical and MRI follow-up study","volume":"234","author":"S Hagman","year":"2011","journal-title":"Journal of neuroimmunology"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis. 2010 revisions to the McDonald criteria","volume":"69","author":"CH Polman","year":"2011","journal-title":"Annals of neurology"},{"issue":"7","key":"ref26","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/clinchem\/37.7.1153","article-title":"Quantification of virus-specific antibodies in cerebrospinal fluid and serum. Sensitive and specific detection of antibody synthesis in brain","volume":"37","author":"H Reiber","year":"1991","journal-title":"Clinical chemistry"},{"issue":"11","key":"ref27","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis. An expanded disability status scale (EDSS)","volume":"33","author":"JF Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10633-009-9195-4","article-title":"ISCEV standard for clinical visual evoked potentials (2009 update)","volume":"120","author":"JV Odom","year":"2010","journal-title":"Documenta ophthalmologica. Advances in ophthalmology"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"6896","DOI":"10.4049\/jimmunol.0803710","article-title":"The Golgi-associated protein p115 mediates the secretion of macrophage migration inhibitory factor","volume":"182","author":"M Merk","year":"2009","journal-title":"Journal of immunology (Baltimore, Md.: 1950)"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"e0146482","DOI":"10.1371\/journal.pone.0146482","article-title":"Macrophage Migration Inhibitory Factor Secretion Is Induced by Ionizing Radiation and Oxidative Stress in Cancer Cells","volume":"11","author":"Y Gupta","year":"2016","journal-title":"PloS one"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pdpdt.2014.12.013","article-title":"ALA-mediated photodynamic effect on apoptosis induction and secretion of macrophage migration inhibitory factor (MIF) and of monocyte chemotactic protein (MCP-1) by colon cancer cells in normoxia and in hypoxia-like conditions in vitro","volume":"12","author":"A Kawczyk-Krupka","year":"2015","journal-title":"Photodiagnosis and photodynamic therapy"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cyto.2012.03.014","article-title":"D-dopachrome tautomerase (D-DT or MIF-2). Doubling the MIF cytokine family","volume":"59","author":"M Merk","year":"2012","journal-title":"Cytokine"},{"issue":"1","key":"ref33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s002210050381","article-title":"Effects of macrophage migration inhibitory factor and macrophage migration stimulatory factor on function and survival of foetal dopaminergic grafts in the 6-hydroxydopamine rat model of Parkinson's disease","volume":"120","author":"SC Schwarz","year":"1998","journal-title":"Experimental brain research"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1084\/jem.179.6.1895","article-title":"The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor","volume":"179","author":"T Calandra","year":"1994","journal-title":"The Journal of experimental medicine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1186\/1471-2407-14-630","article-title":"Macrophage migration inhibitory factor engages PI3K\/Akt signalling and is a prognostic factor in metastatic melanoma","volume":"14","author":"CS Oliveira","year":"2014","journal-title":"BMC cancer"},{"issue":"26","key":"ref36","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1038\/onc.2017.1","article-title":"Macrophage migration inhibitory factor downregulation. A novel mechanism of resistance to anti-angiogenic therapy","volume":"36","author":"BA Castro","year":"2017","journal-title":"Oncogene"},{"issue":"9","key":"ref37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/10799900050151030","article-title":"Increased stability of macrophage migration inhibitory factor (MIF) in DU-145 prostate cancer cells","volume":"20","author":"K Meyer-Siegler","year":"2000","journal-title":"Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research"},{"issue":"11","key":"ref38","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.bbamcr.2009.09.007","article-title":"Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation","volume":"1793","author":"J Lugrin","year":"2009","journal-title":"Biochimica et biophysica acta"},{"issue":"5","key":"ref39","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1210\/jc.2004-1900","article-title":"Marked increase in macrophage migration inhibitory factor synthesis and secretion in human endometrial cells in response to human chorionic gonadotropin hormone","volume":"90","author":"A Akoum","year":"2005","journal-title":"The Journal of clinical endocrinology and metabolism"},{"issue":"12","key":"ref40","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1002\/eji.200535413","article-title":"Macrophage migration inhibitory factor promotes innate immune responses by suppressing glucocorticoid-induced expression of mitogen-activated protein kinase phosphatase-1","volume":"35","author":"T Roger","year":"2005","journal-title":"European journal of immunology"},{"issue":"9","key":"ref41","first-page":"577","article-title":"2012","volume":"48","author":"HA Mucke","journal-title":"Drugs of today (Barcelona, Spain: 1998)"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1021\/jm401908w","article-title":"Discovery of novel inhibitors targeting the macrophage migration inhibitory factor via structure-based virtual screening and bioassays","volume":"57","author":"L Xu","year":"2014","journal-title":"Journal of medicinal chemistry"},{"issue":"7","key":"ref43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1136\/ard.2008.092163","article-title":"Dose-related patterns of glucocorticoid-induced side effects","volume":"68","author":"D Huscher","year":"2009","journal-title":"Annals of the rheumatic diseases"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2018.06.009","article-title":"Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis. In silico and in vivo evidences","volume":"322","author":"P Fagone","year":"2018","journal-title":"Journal of neuroimmunology"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/ana.24408","article-title":"Cerebrospinal fluid markers reveal intrathecal inflammation in progressive multiple sclerosis","volume":"78","author":"M Komori","year":"2015","journal-title":"Annals of neurology"},{"issue":"10","key":"ref46","doi-asserted-by":"crossref","first-page":"e77163","DOI":"10.1371\/journal.pone.0077163","article-title":"Relationship between cerebrospinal fluid biomarkers for inflammation, demyelination and neurodegeneration in acute optic neuritis","volume":"8","author":"S Modvig","year":"2013","journal-title":"PloS one"},{"issue":"4","key":"ref47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1155\/2006\/509476","article-title":"Multiple Sclerosis Cerebrospinal Fluid Biomarkers","volume":"22","author":"G Giovannoni","year":"2006","journal-title":"Disease Markers"},{"issue":"3","key":"ref48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.neures.2011.07.1821","article-title":"Macrophage migration inhibitory factor activates cyclooxygenase 2-prostaglandin E2 in cultured spinal microglia","volume":"71","author":"F Wang","year":"2011","journal-title":"Neuroscience research"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0207726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T01:36:07Z","timestamp":1605490567000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0207726"}},"subtitle":[],"editor":[{"given":"Christoph","family":"Kleinschnitz","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":48,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0207726","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2018,11,26]]}}}